# Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

> **NCT04624490** · PHASE1 · RECRUITING · sponsor: **Mario Castro, MD, MPH** · enrollment: 260 (estimated)

## Conditions studied

- Asthma
- COPD
- Interstitial Lung Disease
- Cystic Fibrosis
- Pulmonary Hypertension
- Pulmonary Infection
- Other Lung Disease

## Interventions

- **DRUG:** Hyperpolarized Xe129

## Key facts

- **NCT ID:** NCT04624490
- **Lead sponsor:** Mario Castro, MD, MPH
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-11-02
- **Primary completion:** 2028-10-26
- **Final completion:** 2028-10-26
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04624490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04624490, "Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04624490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*